Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$83.55 USD

83.55
528,530

-0.94 (-1.11%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $83.58 +0.03 (0.04%) 7:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems

by Zacks Equity Research

Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article.

Indrajit Bandyopadhyay headshot

4 Stocks to Watch Amid Dental Supplies Industry Challenges

by Indrajit Bandyopadhyay

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.

Zacks Equity Research

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

by Zacks Equity Research

AngioDynamics' latest regulatory approval is likely to pave the way for an alternative to conventional radical surgery and improve patient outcomes.

Zacks Equity Research

RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI

by Zacks Equity Research

RadNet's latest collaboration aims to create an AI-powered SmartTechnology to improve patient experience and operational efficiency in ultrasound.

Zacks Equity Research

MMSI or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MMSI vs. WST: Which Stock Is the Better Value Option?

Zacks Equity Research

MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial

by Zacks Equity Research

The significant improvement in patency rates for AVG patients via Merit Medical's WRAPSODY device is expected to enhance patients' vascular access survival.

Zacks Equity Research

Community Health to Sell Florida Hospital to AdventHealth for $265M

by Zacks Equity Research

CYH enters an agreement to sell ShorePoint Health System assets in Florida for $265 million, advancing its strategy to shed non-core facilities and enhance focus on growth areas.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)

by Zacks Equity Research

Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

by Zacks Equity Research

MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.

Zacks Equity Research

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Zacks Equity Research

Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

BDX or MMSI: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

BDX vs. MMSI: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"

by Zacks Equity Research

Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin

by Zacks Equity Research

Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.

Zacks Equity Research

Compared to Estimates, Merit Medical (MMSI) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Merit Medical (MMSI) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 7.50% and 1.44%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BDX vs. MMSI: Which Stock Is the Better Value Option?

by Zacks Equity Research

BDX vs. MMSI: Which Stock Is the Better Value Option?

Zacks Equity Research

Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?

by Zacks Equity Research

MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.

Zacks Equity Research

Here's Why You Should Retain Merit Medical Stock in Your Portfolio

by Zacks Equity Research

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.